The entry of Norges Bank and RenTech suggests growing institutional confidence in BSX’s long-term fundamentals or upcoming catalysts. Traders should monitor for follow-on buying from other active managers and watch for any shift in analyst sentiment or upcoming product approvals.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $76.13entry
- T+1 · 9mo ago −3.09%α −2.17% · $73.78
- T+5 · 8mo ago −5.57%α −4.36% · $71.89
- T+20 · 8mo ago −17.35%α −9.41% · $62.92
- T+60 · 6mo ago −24.28%α −33.61% · $57.64
How similar events traded
Executive Summary
Three major institutions, Norges Bank, Mawer Investment Management, and Renaissance Technologies, significantly increased their positions in Boston Scientific (BSX) during Q4 2025, collectively adding $2.34B in new exposure. This buying was partially offset by a $1.05B reduction from BofA, a mega-passive fund, likely due to index rebalancing or portfolio optimization. The cluster reflects strong new conviction from active and sovereign investors.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.3B
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | NEW | +0% | $2.2B | $2.2B |
| Mawer | NEW | +0% | $4.4M | $4.4M |
| RenTech | DOUBLED | +159.8% | $227.2M | $137.7M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| BofA | TRIM | -28.8% | $3.4B | -$1.0B |
Key Facts
- Norges Bank established a new $2.20B position (23.07M shares), signaling strong sovereign-level conviction.
- RenTech (Renaissance Technologies) more than doubled its stake, adding $137.7M in value, indicating growing interest from quant-driven strategies.
- Mawer, an active value manager, initiated a $4.4M position, reinforcing fundamental appeal.
- BofA trimmed its holding by 28.8%, reducing exposure by $1.05B, but remains a large holder at $2.39B.
Financial Impact
Net institutional accumulation of $1.29B ($2.34B in new buys, -$1.05B in sells), representing meaningful capital inflow from high-conviction managers.
Risk Factors
- The large sell-side move by BofA, while passive, could indicate broader de-risking or index-related outflows.
- BSX remains sensitive to medical device regulatory timelines and competitive dynamics in cardiac rhythm management.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BSX-2025-Q4 |
Track record
22 reports on BSX
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 8 went positive at some point.
Filters
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 settles Nov 25
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 settles Nov 20
- Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 ▲ +10.20% +11.54% vs SPY
- Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 ▲ +0.25% +0.93% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 ▼ −9.21% −9.57% vs SPY
- Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 ▲ +9.24% +10.44% vs SPY
- Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 ▼ −8.35% −9.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 ▼ −10.86% −9.95% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 ▼ −10.86% −9.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers